Related Experiment Video
Updated: Apr 12, 2026

08:52
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
9.4K
Gliosarcoma with primitive neuroectodermal, osseous, cartilage and adipocyte differentiation: a case report.
Kun Yao1, Xue-Ling Qi2, Xi Mei3
1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University Beijing, China.
Summary
This study details a rare gliosarcoma case in a 57-year-old man, exhibiting diverse differentiation including primitive neuroectodermal, bone, cartilage, and fat. This finding enhances understanding of complex brain tumor pathology.
Area of Science:
- Neuro-oncology
- Pathology
- Molecular Genetics
Background:
- Gliosarcoma is a rare, aggressive primary brain tumor characterized by a biphasic pattern of glial and sarcomatous components.
- Understanding the diverse differentiation potential within gliosarcoma is crucial for accurate diagnosis and treatment strategies.
Observation:
- A 57-year-old male presented with symptoms of increased intracranial pressure, including severe headache, nausea, and vomiting.
- Magnetic resonance imaging revealed a right frontal lobe lesion necessitating surgical intervention.
- Histopathological examination identified a tumor with glial (anaplastic astrocytoma-like) and sarcomatous elements, alongside primitive neuroectodermal, osseous, cartilaginous, and adipocytic differentiation.
Findings:
- Immunohistochemistry confirmed GFAP positivity in glial components, S-100, Fli-1, Nestin, MAP-2, and Syn in the primitive neuroectodermal-like cells, and vimentin in the sarcomatous areas.
- Molecular analysis revealed PTEN allele loss without EGFR amplification in all tumor components.
- The combination of histological and immunohistochemical findings supports a diagnosis of gliosarcoma with extensive divergent differentiation.
Implications:
- This case expands the known spectrum of differentiation within gliosarcoma, highlighting its capacity for multipotent differentiation.
- Accurate characterization of such rare tumors is essential for advancing diagnostic criteria and exploring targeted therapeutic approaches.
- Further research into the molecular mechanisms driving this extensive differentiation may reveal novel therapeutic targets for gliosarcoma.

